Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
GJA9	81025	broad.mit.edu	37	1	39340248	39340248	+	Missense_Mutation	SNP	C	C	A			THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	g.chr1:39340248C>A	ENST00000357771.3	-	2	1803	c.1523G>T	c.(1522-1524)cGg>cTg	p.R508L	GJA9_ENST00000454994.2_Intron|RP5-864K19.4_ENST00000433671.2_RNA|MYCBP_ENST00000397572.2_5'Flank|RP5-864K19.4_ENST00000443161.1_RNA|MYCBP_ENST00000489803.1_5'UTR|RP5-864K19.4_ENST00000456813.1_RNA|GJA9_ENST00000360786.3_Missense_Mutation_p.R508L	NM_030772.4	NP_110399.2	P57773	CXA9_HUMAN	gap junction protein, alpha 9, 59kDa	508		NA			cell communication	connexon complex|integral to membrane				breast(3)|cervix(1)|endometrium(1)|kidney(2)|large_intestine(3)|lung(7)|upper_aerodigestive_tract(1)|urinary_tract(1)	19	Acute lymphoblastic leukemia(166;0.074)	Myeloproliferative disorder(586;0.0393)	OV - Ovarian serous cystadenocarcinoma(33;8.23e-17)			TGTGGGAACCCGCCTACCAAT	0.453		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						74	75	75	NA		NA	NA	1		NA											NA				39340248		2203	4300	6503	SO:0001583	missense			ENSG00000131233	HGNC:19155	NM_030772	Approved	uc021olr.1	NA	B2R722|B3KVQ2|Q5TA63|Q96KG0	ENST00000357771.3	37	CCDS432.1	.	.	.	.	.	.	.	.	.	.	C	20.9	4.063030	0.76187	.	.	ENSG00000131233	ENST00000357771;ENST00000360786	D;D	0.98835	-5.17;-5.17	4.02	3.06	0.35304	.	0.839490	0.09936	N	0.736599	D	0.97486	0.9177	L	0.27053	0.805	0.35245	D	0.778145	D	0.59767	0.986	P	0.55011	0.766	D	0.95812	0.8842	10	0.72032	D	0.01	.	10.3863	0.44143	0.0:0.8938:0.0:0.1062	.	508	P57773	CXA9_HUMAN	L	508	ENSP00000350415:R508L;ENSP00000354020:R508L	ENSP00000350415:R508L	R	-	2	0	GJA9	39112835	1.000000	0.71417	0.992000	0.48379	0.878000	0.50629	3.245000	0.51407	0.921000	0.36994	0.563000	0.77884	CGG	GJA9-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		-12.451793	KEEP		-	9.90644	0.0625	7	105	---	---	---	---	1	0.2213194	11	0	0	100	8	123	0	100	2	0	0	0	0	0	100	8	123	0	100	2	TP
NRAS	4893	broad.mit.edu	37	1	115256529	115256529	+	Missense_Mutation	SNP	T	T	C	rs11554290		THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	g.chr1:115256529T>C	ENST00000369535.4	-	3	435	c.182A>G	c.(181-183)cAa>cGa	p.Q61R		NM_002524.4	NP_002515.1	P01111	RASN_HUMAN	neuroblastoma RAS viral (v-ras) oncogene homolog	61		NA	Q -> K (in neuroblastoma cell).|Q -> R (in lung carcinoma cell and melanoma; dbSNP:rs11554290).		activation of MAPKK activity|axon guidance|blood coagulation|epidermal growth factor receptor signaling pathway|insulin receptor signaling pathway|leukocyte migration|nerve growth factor receptor signaling pathway|Ras protein signal transduction	Golgi membrane|plasma membrane	GTP binding|GTPase activity	p.Q61R(817)|p.Q61L(175)|p.Q61P(23)|p.Q61K(1)		NS(134)|adrenal_gland(9)|autonomic_ganglia(9)|biliary_tract(6)|bone(1)|breast(9)|central_nervous_system(10)|cervix(2)|endometrium(11)|eye(3)|haematopoietic_and_lymphoid_tissue(1115)|kidney(3)|large_intestine(105)|liver(10)|lung(42)|meninges(2)|ovary(7)|pancreas(5)|prostate(8)|skin(1144)|soft_tissue(37)|stomach(5)|testis(8)|thyroid(359)|upper_aerodigestive_tract(28)|urinary_tract(13)	3085	all_epithelial(7;5.11e-05)|all_lung(7;0.000179)|Lung NSC(6;0.00195)|Lung SC(450;0.211)	all_cancers(81;4.64e-07)|all_epithelial(167;4.2e-07)|all_lung(203;9.97e-06)|Lung NSC(69;1.74e-05)		Lung(183;0.0234)|Colorectal(144;0.0686)|COAD - Colon adenocarcinoma(174;0.111)|all cancers(265;0.112)|Epithelial(280;0.124)|LUSC - Lung squamous cell carcinoma(189;0.133)		GTACTCTTCTTGTCCAGCTGT	0.458	Q61L(C3A_LIVER)|Q61L(HEPG2_LIVER)|Q61L(HL60_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|Q61L(IPC298_SKIN)|Q61L(KMS21BM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|Q61L(MELJUSO_SKIN)|Q61L(MHHES1_BONE)|Q61L(MOLP8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|Q61L(OCIAML3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|Q61P(TF1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|Q61R(HT1197_URINARY_TRACT)|Q61R(KMS27_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|Q61R(KU1919_URINARY_TRACT)|Q61R(NCIH2347_LUNG)|Q61R(ONS76_CENTRAL_NERVOUS_SYSTEM)|Q61R(SKMEL2_SKIN)|Q61R(SW1271_LUNG)|Q61R(TT2609C02_THYROID)	50	Mis		"""melanoma, MM, AML, thyroid"""		NA		Noonan syndrome	TSP Lung(23;0.16)|Multiple Myeloma(1;<1E-6)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA				Dom	yes		1	1p13.2	4893	neuroblastoma RAS viral (v-ras) oncogene homolog	NA	"""L, E"""	1016	Substitution - Missense(1016)	skin(466)|thyroid(279)|haematopoietic_and_lymphoid_tissue(124)|NS(50)|large_intestine(27)|lung(17)|urinary_tract(11)|adrenal_gland(7)|liver(7)|breast(7)|soft_tissue(4)|testis(3)|endometrium(3)|ovary(3)|central_nervous_system(2)|pancreas(2)|eye(1)|prostate(1)|meninges(1)|autonomic_ganglia(1)					NA						180	156	164	NA		NA	NA	1		NA											NA				115256529		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Male Turner syndrome, Pterygium Colli syndrome, incl. Noonan-like/Multiple Giant Cell Lesion syndrome; Noonan s. with multiple lentigines/LEOPARD syndrome	ENSG00000213281	HGNC:7989	NM_002524	Approved	uc009wgu.3	NA	Q14971|Q15104|Q15282	ENST00000369535.4	37	CCDS877.1	.	.	.	.	.	.	.	.	.	.	T	20.5	4.004139	0.74932	.	.	ENSG00000213281	ENST00000369535	D	0.83673	-1.75	5.08	5.08	0.68730	Small GTP-binding protein domain (1);	0.000000	0.53938	U	0.000043	D	0.86489	0.5945	M	0.92604	3.325	0.80722	D	1	B	0.28512	0.214	B	0.39590	0.304	D	0.88255	0.2919	10	0.66056	D	0.02	.	15.0132	0.71565	0.0:0.0:0.0:1.0	rs11554290;rs11554290	61	P01111	RASN_HUMAN	R	61	ENSP00000358548:Q61R	ENSP00000358548:Q61R	Q	-	2	0	NRAS	115058052	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	7.761000	0.85260	2.120000	0.65058	0.533000	0.62120	CAA	NRAS-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000033395.2	158.817759	KEEP		-	162.248466	0.34375	55	105	---	---	---	---	1	1	30	38	0	116	62	116	0	116	2	1	1	56	68	0	116	62	116	0	116	2	TP
FAHD2A	51011	broad.mit.edu	37	2	96071494	96071494	+	Missense_Mutation	SNP	C	C	A			THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	g.chr2:96071494C>A	ENST00000233379.4	+	2	341	c.188C>A	c.(187-189)cCg>cAg	p.P63Q	FAHD2A_ENST00000447036.1_Missense_Mutation_p.P63Q	NM_016044.2	NP_057128.2	Q96GK7	FAH2A_HUMAN	fumarylacetoacetate hydrolase domain containing 2A	63		NA					hydrolase activity|metal ion binding			breast(1)|cervix(1)|endometrium(1)|kidney(1)|lung(3)|ovary(1)	8						CCCACACTCCCGAAGACGATG	0.607		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						113	86	95	NA		NA	NA	2		NA											NA				96071494		2203	4300	6503	SO:0001583	missense			ENSG00000115042	HGNC:24252	NM_016044	Approved	uc002sur.3	NA	Q9Y3B0	ENST00000233379.4	37	CCDS2014.1	.	.	.	.	.	.	.	.	.	.	C	14.80	2.643298	0.47153	.	.	ENSG00000115042	ENST00000445649;ENST00000447036;ENST00000233379;ENST00000418606	T;T	0.34859	1.34;1.34	2.79	2.79	0.32731	.	0.000000	0.85682	D	0.000000	T	0.60405	0.2266	M	0.85859	2.78	0.47037	D	0.999297	D	0.76494	0.999	D	0.77004	0.989	T	0.67248	-0.5718	10	0.72032	D	0.01	.	11.3227	0.49433	0.0:1.0:0.0:0.0	.	63	Q96GK7	FAH2A_HUMAN	Q	63	ENSP00000406424:P63Q;ENSP00000233379:P63Q	ENSP00000233379:P63Q	P	+	2	0	FAHD2A	95435221	1.000000	0.71417	0.951000	0.38953	0.389000	0.30415	5.931000	0.70113	1.551000	0.49450	0.491000	0.48974	CCG	FAHD2A-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000252778.1	-4.409105	KEEP		+	10.425404	0.075	6	74	---	---	---	---	1	0.999525	2	229	0	69	6	77	0	69	2	0	0	0	0	0	69	6	77	0	69	2	TP
EEF1B2	1933	broad.mit.edu	37	2	207025358	207025358	+	Missense_Mutation	SNP	A	A	G			THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	g.chr2:207025358A>G	ENST00000392222.2	+	2	502	c.127A>G	c.(127-129)Agc>Ggc	p.S43G	NDUFS1_ENST00000233190.5_5'Flank|NDUFS1_ENST00000457011.1_5'Flank|NDUFS1_ENST00000455934.2_5'Flank|NDUFS1_ENST00000449699.1_5'Flank|NDUFS1_ENST00000440274.1_5'Flank|NDUFS1_ENST00000432169.1_5'Flank|EEF1B2_ENST00000392221.1_Missense_Mutation_p.S43G|NDUFS1_ENST00000423725.1_5'Flank|SNORA41_ENST00000384675.1_RNA|EEF1B2_ENST00000236957.5_Missense_Mutation_p.S43G|SNORD51_ENST00000384320.2_RNA	NM_001959.3	NP_001950.1	P24534	EF1B_HUMAN	eukaryotic translation elongation factor 1 beta 2	43	GST C-terminal.	NA				cytosol|eukaryotic translation elongation factor 1 complex	protein binding|translation elongation factor activity	p.S43G(4)		breast(1)|endometrium(5)|kidney(3)|large_intestine(1)|lung(6)	16						AGCCGTGTCCAGCCCACCGCC	0.468		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		4	Substitution - Missense(4)	endometrium(2)|lung(1)|kidney(1)					NA						109	99	102	NA		NA	NA	2		NA											NA				207025358		2203	4300	6503	SO:0001583	missense			ENSG00000114942	HGNC:3208	NM_001037663	Approved	uc002vbf.1	NA	A8K795|Q6IBH9	ENST00000392222.2	37	CCDS2367.1	.	.	.	.	.	.	.	.	.	.	A	0.014	-1.585588	0.00872	.	.	ENSG00000114942	ENST00000236957;ENST00000392221;ENST00000392222;ENST00000445505	T;T;T;T	0.44482	0.92;0.92;0.92;0.92	5.47	0.911	0.19343	Glutathione S-transferase, C-terminal-like (2);	0.442134	0.26800	N	0.022437	T	0.19846	0.0477	N	0.16098	0.37	0.09310	N	1	B	0.02656	0.0	B	0.01281	0.0	T	0.18745	-1.0327	10	0.17832	T	0.49	-2.1703	6.3337	0.21285	0.2348:0.0:0.6384:0.1268	.	43	P24534	EF1B_HUMAN	G	43	ENSP00000236957:S43G;ENSP00000376055:S43G;ENSP00000376056:S43G;ENSP00000407730:S43G	ENSP00000236957:S43G	S	+	1	0	EEF1B2	206733603	0.049000	0.20398	0.145000	0.22337	0.051000	0.14879	0.879000	0.28146	-0.027000	0.13873	-0.252000	0.11476	AGC	EEF1B2-003	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000336436.1	-19.23758	KEEP		+	6.419483	0.028571	3	102	G	PoN.13Oct2012	Reference	THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	1	0.9999964	6	3828	0	70	3	114	0	70	2	0	0	0	0	0	70	3	114	0	70	2	TP
IRS1	3667	broad.mit.edu	37	2	227661463	227661463	+	Missense_Mutation	SNP	C	C	A			THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	g.chr2:227661463C>A	ENST00000305123.4	-	1	3012	c.1992G>T	c.(1990-1992)atG>atT	p.M664I	IRS1_ENST00000498335.1_5'Flank	NM_005544.2	NP_005535.1	P35568	IRS1_HUMAN	insulin receptor substrate 1	664		NA			fibroblast growth factor receptor signaling pathway|glucose homeostasis|insulin receptor signaling pathway|negative regulation of insulin receptor signaling pathway|negative regulation of insulin secretion|nerve growth factor receptor signaling pathway|phosphatidylinositol 3-kinase cascade|phosphatidylinositol-mediated signaling|positive regulation of fatty acid beta-oxidation|positive regulation of glucose import|positive regulation of glycogen biosynthetic process|positive regulation of insulin receptor signaling pathway|positive regulation of phosphatidylinositol 3-kinase activity	caveola|cytosol|insulin receptor complex|microsome|nucleus	insulin receptor binding|insulin-like growth factor receptor binding|phosphatidylinositol 3-kinase binding|protein kinase C binding|SH2 domain binding|transmembrane receptor protein tyrosine kinase adaptor activity			autonomic_ganglia(1)|breast(2)|central_nervous_system(4)|endometrium(5)|kidney(4)|large_intestine(10)|lung(33)|ovary(6)|pancreas(1)|prostate(1)|urinary_tract(2)	69		Renal(207;0.023)|all_lung(227;0.0994)|all_hematologic(139;0.118)|Esophageal squamous(248;0.23)		Epithelial(121;3.03e-11)|all cancers(144;2.42e-08)|Lung(261;0.00712)|LUSC - Lung squamous cell carcinoma(224;0.0137)		TGGGGGACATCATCATGTAGC	0.597		NA					NA				OREG0015248	type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip)		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						78	75	76	NA		NA	NA	2		NA											NA				227661463		2203	4300	6503	SO:0001583	missense			ENSG00000169047	HGNC:6125	NM_005544	Approved	uc002voh.4	2321		ENST00000305123.4	37	CCDS2463.1	.	.	.	.	.	.	.	.	.	.	C	10.79	1.449111	0.26074	.	.	ENSG00000169047	ENST00000305123	T	0.58652	0.32	4.81	4.81	0.61882	.	0.000000	0.85682	D	0.000000	T	0.48040	0.1478	L	0.39898	1.24	0.36619	D	0.875622	P	0.39831	0.69	B	0.33454	0.164	T	0.58375	-0.7647	10	0.37606	T	0.19	-15.0102	18.0712	0.89407	0.0:1.0:0.0:0.0	.	664	P35568	IRS1_HUMAN	I	664	ENSP00000304895:M664I	ENSP00000304895:M664I	M	-	3	0	IRS1	227369707	1.000000	0.71417	1.000000	0.80357	0.927000	0.56198	3.586000	0.53950	2.504000	0.84457	0.561000	0.74099	ATG	IRS1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000256886.2	-13.244564	KEEP		-	7.864308	0.058252	6	97	---	---	---	---	1	0.9299462	2	71	0	55	7	107	0	55	2	0	0	0	0	0	55	7	107	0	55	2	TP
CTNNB1	1499	broad.mit.edu	37	3	41275668	41275668	+	Silent	SNP	C	C	A			THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	g.chr3:41275668C>A	ENST00000349496.5	+	10	1843	c.1563C>A	c.(1561-1563)ccC>ccA	p.P521P	CTNNB1_ENST00000405570.1_Silent_p.P521P|CTNNB1_ENST00000396183.3_Silent_p.P521P|CTNNB1_ENST00000396185.3_Silent_p.P521P|CTNNB1_ENST00000453024.1_Silent_p.P514P	NM_001904.3	NP_001895.1	P35222	CTNB1_HUMAN	catenin (cadherin-associated protein), beta 1, 88kDa	521		NA			adherens junction assembly|androgen receptor signaling pathway|branching involved in ureteric bud morphogenesis|canonical Wnt receptor signaling pathway involved in negative regulation of apoptosis|canonical Wnt receptor signaling pathway involved in positive regulation of epithelial to mesenchymal transition|cell-cell adhesion|cell-matrix adhesion|cellular component disassembly involved in apoptosis|cellular response to growth factor stimulus|cellular response to indole-3-methanol|central nervous system vasculogenesis|cytoskeletal anchoring at plasma membrane|determination of dorsal/ventral asymmetry|dorsal/ventral axis specification|ectoderm development|embryonic axis specification|embryonic foregut morphogenesis|embryonic leg joint morphogenesis|endodermal cell fate commitment|endothelial tube morphogenesis|epithelial to mesenchymal transition|gastrulation with mouth forming second|glial cell fate determination|hair follicle morphogenesis|hair follicle placode formation|hindbrain development|liver development|lung cell differentiation|lung induction|lung-associated mesenchyme development|male genitalia development|mesenchymal cell proliferation involved in lung development|mesenchymal to epithelial transition involved in metanephros morphogenesis|negative regulation of cell proliferation|negative regulation of chondrocyte differentiation|negative regulation of heart induction by canonical Wnt receptor signaling pathway|negative regulation of osteoclast differentiation|negative regulation of transcription from RNA polymerase II promoter|nephron tubule formation|odontogenesis of dentine-containing tooth|oocyte development|pancreas development|positive regulation of anti-apoptosis|positive regulation of apoptosis|positive regulation of branching involved in lung morphogenesis|positive regulation of epithelial cell proliferation involved in prostate gland development|positive regulation of fibroblast growth factor receptor signaling pathway|positive regulation of heparan sulfate proteoglycan biosynthetic process|positive regulation of I-kappaB kinase/NF-kappaB cascade|positive regulation of MAPKKK cascade|positive regulation of muscle cell differentiation|positive regulation of osteoblast differentiation|positive regulation of transcription from RNA polymerase II promoter|protein localization at cell surface|proximal/distal pattern formation|regulation of angiogenesis|regulation of calcium ion import|regulation of centriole-centriole cohesion|regulation of centromeric sister chromatid cohesion|regulation of fibroblast proliferation|regulation of nephron tubule epithelial cell differentiation|regulation of protein localization at cell surface|regulation of smooth muscle cell proliferation|regulation of T cell proliferation|renal inner medulla development|renal outer medulla development|renal vesicle formation|response to drug|response to estradiol stimulus|Schwann cell proliferation|smooth muscle cell differentiation|synapse organization|synaptic vesicle transport|T cell differentiation in thymus|thymus development|trachea formation	APC-Axin-1-beta-catenin complex|Axin-APC-beta-catenin-GSK3B complex|beta-catenin-TCF7L2 complex|catenin complex|cell cortex|cell-substrate adherens junction|centrosome|dendritic shaft|desmosome|fascia adherens|internal side of plasma membrane|lamellipodium|lateral plasma membrane|microvillus membrane|perinuclear region of cytoplasm|protein-DNA complex|synapse|transcription factor complex|Z disc|zonula adherens	alpha-catenin binding|androgen receptor binding|cadherin binding|estrogen receptor binding|I-SMAD binding|ion channel binding|protein binding|protein C-terminus binding|protein kinase binding|protein phosphatase binding|R-SMAD binding|RPTP-like protein binding|signal transducer activity|specific RNA polymerase II transcription factor activity|structural molecule activity|transcription coactivator activity|transcription regulatory region DNA binding		CTNNB1/PLAG1(60)	NS(4)|adrenal_gland(103)|biliary_tract(43)|bone(21)|breast(7)|central_nervous_system(260)|cervix(9)|endometrium(293)|eye(1)|haematopoietic_and_lymphoid_tissue(60)|kidney(202)|large_intestine(269)|liver(1010)|lung(63)|oesophagus(6)|ovary(106)|pancreas(126)|parathyroid(11)|pituitary(111)|pleura(2)|prostate(31)|salivary_gland(13)|skin(103)|small_intestine(17)|soft_tissue(792)|stomach(165)|thyroid(55)|upper_aerodigestive_tract(2)|urinary_tract(8)	3893				KIRC - Kidney renal clear cell carcinoma(284;0.0028)|Kidney(284;0.00294)	Lithium(DB01356)	CCCTTTGTCCCGCAAATCATG	0.463		15	"""H, Mis, T"""	PLAG1	"""colorectal, cvarian,  hepatoblastoma, others, pleomorphic salivary adenoma"""		NA		Pilomatrixoma, Familial Clustering of					NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Colon(6;3 56 14213 18255)		Dom	yes		3	3p22-p21.3	1499	"""catenin (cadherin-associated protein), beta 1"""	NA	"""E, M, O"""	0							NA						157	136	143	NA		NA	NA	3		NA											NA				41275668		2203	4300	6503	SO:0001819	synonymous_variant	Familial Cancer Database	Pilomatricoma, Familial Clustering of, Epithelioma Calcificans of Malherbe	ENSG00000168036	HGNC:2514	NM_001098210	Approved	uc003ckr.2	NA	A8K1L7|Q8NEW9|Q8NI94|Q9H391	ENST00000349496.5	37	CCDS2694.1																																																																																			CTNNB1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000254182.2	-4.3782	KEEP		+	7.814421	0.075758	5	61	---	---	---	---	1	1	2	1078	0	62	6	67	0	62	2	0	0	0	0	0	62	6	67	0	62	2	TP
TMA16	55319	broad.mit.edu	37	4	164436550	164436550	+	Silent	SNP	C	C	A			THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	g.chr4:164436550C>A	ENST00000358572.5	+	5	666	c.325C>A	c.(325-327)Cgg>Agg	p.R109R	TMA16_ENST00000508268.1_Silent_p.R109R|TMA16_ENST00000513134.1_Intron|TMA16_ENST00000511562.1_3'UTR|TMA16_ENST00000513272.1_Intron	NM_018352.2	NP_060822.2	Q96EY4	CD043_HUMAN	translation machinery associated 16 homolog (S. cerevisiae)	109		NA									NA						GCACTGTTCCCGGGAGACCGT	0.478		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						121	129	126	NA		NA	NA	4		NA											NA				164436550		1975	4155	6130	SO:0001819	synonymous_variant			ENSG00000198498	HGNC:25638	NM_018352	Approved	uc003iqq.4	NA	Q0P6E4|Q0P6J1|Q9NUR7	ENST00000358572.5	37	CCDS43278.1	.	.	.	.	.	.	.	.	.	.	C	11.02	1.517317	0.27123	.	.	ENSG00000198498	ENST00000509657	.	.	.	5.49	5.49	0.81192	.	.	.	.	.	T	0.69504	0.3118	.	.	.	0.80722	D	1	.	.	.	.	.	.	T	0.67043	-0.5770	4	.	.	.	-3.9986	14.0719	0.64865	0.1513:0.8486:0.0:0.0	.	.	.	.	Q	147	.	.	P	+	2	0	C4orf43	164656000	1.000000	0.71417	1.000000	0.80357	0.992000	0.81027	3.002000	0.49496	2.744000	0.94065	0.650000	0.86243	CCG	TMA16-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000365208.1	-8.858907	KEEP		+	8.670761	0.074468	7	87	---	---	---	---	1	0.98118	5	97	0	112	7	96	0	112	2	0	0	0	0	0	112	7	96	0	112	2	TP
HLA-A	3105	broad.mit.edu	37	6	29910607	29910607	+	Silent	SNP	G	G	C	rs72555397		THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	g.chr6:29910607G>C	ENST00000396634.1	+	4	488	c.147G>C	c.(145-147)gtG>gtC	p.V49V	HLA-A_ENST00000376809.5_Silent_p.V49V|HLA-A_ENST00000376806.5_Silent_p.V49V|HLA-A_ENST00000376802.2_Silent_p.V49V			P30443	1A01_HUMAN	major histocompatibility complex, class I, A	49	Alpha-1.	NA			antigen processing and presentation of peptide antigen via MHC class I|interferon-gamma-mediated signaling pathway|interspecies interaction between organisms|regulation of immune response|type I interferon-mediated signaling pathway	integral to plasma membrane|MHC class I protein complex	MHC class I receptor activity	p.V49V(2)		central_nervous_system(2)|cervix(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(3)|lung(10)|ovary(1)|prostate(2)|skin(1)|upper_aerodigestive_tract(5)|urinary_tract(2)	30						TCATCGCCGTGGGCTACGTGG	0.692		NA					NA		Osteosarcoma, Familial Clustering of;Naso-/Oropharyngeal/Laryngeal Cancer, Familial Clustering of;Melanoma, Familial Clustering of;Lichen Sclerosis et Atrophicus, Familial Clustering of	Multiple Myeloma(9;0.094)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		2	Substitution - coding silent(2)	lung(1)|kidney(1)					NA						NA	NA	NA	NA		NA	NA			NA											NA				NA		NA	NA	NA	SO:0001819	synonymous_variant	Familial Cancer Database	Familial Osteogenic Sarcoma;incl.: Familial Head and Neck Cancer; ;Lichen Sclerosis, Familial	ENSG00000206503	HGNC:4931	NM_002116	Approved	uc003nol.3	NA	O77964|O78171|Q9MYA3|Q9TP25|Q9TQP5	ENST00000396634.1	37	CCDS34373.1																																																																																			HLA-A-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000252909.1	-0.870627	KEEP		+	6.440188	0.093023	4	39	C	PoN.13Oct2012	Reference	THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	1	1	1177	3551	0	34	4	55	0	34	2	0	0	0	0	0	34	4	55	0	34	2	TP
HCP5	0	broad.mit.edu	37	6	31431525	31431525	+	RNA	SNP	G	G	T			THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	g.chr6:31431525G>T	ENST00000414046.2	+	0	597					NR_040662.1		Q6MZN7	HCP5_HUMAN		NA		NA			defense response					urinary_tract(1)	1						tccttcctgaggggtctgggc	0.547		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						118	125	122	NA		NA	NA	6		NA											NA				31431525		2203	4300	6503										NA	Q04490	ENST00000414046.2	37																																																																																				HCP5-001	KNOWN	basic	sense_overlapping	NA	sense_overlapping	OTTHUMT00000076614.4	-17.053046	KEEP		+	7.923842	0.051282	6	111	---	---	---	---	1	0.3317179	3	30	1	118	7	121	1	118	3	0	0	0	0	1	118	7	121	1	118	2	TP
SLC39A7	7922	broad.mit.edu	37	6	33171491	33171491	+	Silent	SNP	C	C	A			THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	g.chr6:33171491C>A	ENST00000374677.3	+	7	1684	c.1311C>A	c.(1309-1311)ccC>ccA	p.P437P	SLC39A7_ENST00000463972.1_3'UTR|RXRB_ENST00000544186.1_5'Flank|HSD17B8_ENST00000374662.3_5'Flank|SLC39A7_ENST00000374675.3_Silent_p.P437P	NM_006979.2	NP_008910.2	Q92504	S39A7_HUMAN	solute carrier family 39 (zinc transporter), member 7	437		NA		CALLTEGGAVGSEIAGGAGPGWVLPFTAGGFIYVATVSVLP ELLREASPLQSLLEVLGLLGGVIMMVLIAHLE -> VPFSL KEEQWTVKLQVVQVLAGSCHLLQVALST (in Ref. 1; BAA11528 and 2; AAD12305).		endoplasmic reticulum membrane|integral to membrane|membrane fraction	protein binding|zinc ion transmembrane transporter activity			NS(1)|breast(3)|endometrium(2)|large_intestine(5)|lung(4)|upper_aerodigestive_tract(2)|urinary_tract(1)	18						CTGTGTTGCCCGAGCTGCTGA	0.562		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						107	110	109	NA		NA	NA	6		NA											NA				33171491		2065	4201	6266	SO:0001819	synonymous_variant			ENSG00000112473	HGNC:4927	NM_006979	Approved	uc003odf.3	NA	B0UXF6|Q5STP8|Q9UIQ0	ENST00000374677.3	37	CCDS43453.1																																																																																			SLC39A7-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000076499.2	-31.881323	KEEP		+	7.132587	0.030864	5	157	---	---	---	---	1	0.9999554	2	1043	0	105	5	165	0	105	2	0	0	0	0	0	105	5	165	0	105	2	TP
LIMK1	3984	broad.mit.edu	37	7	73535371	73535371	+	Silent	SNP	C	C	A			THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	g.chr7:73535371C>A	ENST00000418310.1	+	15	1965	c.1863C>A	c.(1861-1863)ccC>ccA	p.P621P	LIMK1_ENST00000336180.2_Silent_p.P591P|LIMK1_ENST00000538333.3_Silent_p.P557P			P53667	LIMK1_HUMAN	LIM domain kinase 1	591		NA			actin cytoskeleton organization|axon guidance|negative regulation of ubiquitin-protein ligase activity|positive regulation of actin filament bundle assembly|positive regulation of axon extension|Rho protein signal transduction	cytosol|growth cone|nucleus	ATP binding|heat shock protein binding|protein serine/threonine kinase activity|zinc ion binding			breast(1)|central_nervous_system(2)|cervix(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(6)|ovary(1)|skin(1)|stomach(2)|upper_aerodigestive_tract(1)	21		Lung NSC(55;0.137)				ATCTGGACCCCGAGAAGAGGT	0.672		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						77	84	82	NA		NA	NA	7		NA											NA				73535371		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000106683	HGNC:6613	NM_002314	Approved	uc003uaa.2	NA	D3DXF4|D3DXF5|O15283|Q15820|Q15821|Q75MU3|Q9Y5Q1	ENST00000418310.1	37																																																																																				LIMK1-002	PUTATIVE	not_organism_supported|basic|exp_conf	protein_coding	NA	protein_coding	OTTHUMT00000348344.1	-37.746434	KEEP		+	7.827291	0.027027	5	180	---	---	---	---	1	0.967808	2	255	0	157	5	200	0	157	2	0	0	0	0	0	157	5	200	0	157	2	TP
PIP5K1B	8395	broad.mit.edu	37	9	71439080	71439080	+	Intron	SNP	C	C	A			THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	g.chr9:71439080C>A	ENST00000265382.3	+	4	374				RP11-203L2.4_ENST00000442103.1_RNA|PIP5K1B_ENST00000541509.1_Intron	NM_003558.2	NP_003549.1	O14986	PI51B_HUMAN	phosphatidylinositol-4-phosphate 5-kinase, type I, beta	NA		NA				endomembrane system|membrane|uropod	1-phosphatidylinositol-4-phosphate 5-kinase activity|ATP binding|protein binding			breast(1)|large_intestine(2)|stomach(1)	4				Lung(182;0.133)		AAGCATGGACCAACACAGAGA	0.373		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						436	412	420	NA		NA	NA	9		NA											NA				71439080		876	1991	2867	SO:0001627	intron_variant			ENSG00000107242	HGNC:8995	NM_003558	Approved	uc004agu.4	NA	A8K9L9|P78518|P78519|Q5T5K6|Q5T5K8|Q5T5K9|Q5VZ00|Q7KYT5|Q8NHQ5|Q92749	ENST00000265382.3	37	CCDS6624.1																																																																																			PIP5K1B-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000052561.2	-55.266406	KEEP		+	7.358174	0.027559	7	247	---	---	---	---	1	0.06373787	11	0	0	261	10	284	0	261	2	0	0	0	0	0	261	10	284	0	261	2	TP
ATP6V1G1	9550	broad.mit.edu	37	9	117359862	117359862	+	Missense_Mutation	SNP	C	C	A			THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	g.chr9:117359862C>A	ENST00000374050.3	+	3	289	c.196C>A	c.(196-198)Cgt>Agt	p.R66S		NM_004888.3	NP_004879.1	O75348	VATG1_HUMAN	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1	66		NA			cellular iron ion homeostasis|insulin receptor signaling pathway|proton transport|transferrin transport	cytosol|plasma membrane|vacuolar proton-transporting V-type ATPase complex	ATPase binding|hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances	p.R66S(2)		endometrium(1)|lung(2)|prostate(1)|skin(1)	5						ATTGGGATCCCGTGGCAGTTG	0.502		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		2	Substitution - Missense(2)	lung(2)					NA						93	83	86	NA		NA	NA	9		NA											NA				117359862		2203	4300	6503	SO:0001583	missense			ENSG00000136888	HGNC:864	NM_004888	Approved	uc004bjc.3	NA		ENST00000374050.3	37	CCDS6807.1	.	.	.	.	.	.	.	.	.	.	C	17.64	3.440731	0.63067	.	.	ENSG00000136888	ENST00000374050	T	0.40756	1.02	6.17	6.17	0.99709	.	0.150186	0.64402	D	0.000004	T	0.20577	0.0495	N	0.02202	-0.64	0.40189	D	0.977389	B	0.02656	0.0	B	0.04013	0.001	T	0.28650	-1.0037	10	0.02654	T	1	.	20.8794	0.99867	0.0:1.0:0.0:0.0	.	66	O75348	VATG1_HUMAN	S	66	ENSP00000363162:R66S	ENSP00000363162:R66S	R	+	1	0	ATP6V1G1	116399683	1.000000	0.71417	0.992000	0.48379	0.619000	0.37552	7.210000	0.77924	2.941000	0.99782	0.655000	0.94253	CGT	ATP6V1G1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000055454.1	-11.370609	KEEP		+	6.661616	0.048193	4	79	---	---	---	---	1	0.9999984	3	1760	0	77	4	88	0	77	2	0	0	0	0	0	77	4	88	0	77	2	TP
RABEPK	10244	broad.mit.edu	37	9	127982945	127982945	+	Silent	SNP	C	C	A			THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	g.chr9:127982945C>A	ENST00000373538.3	+	5	802	c.492C>A	c.(490-492)ccC>ccA	p.P164P	RABEPK_ENST00000259460.8_Silent_p.P113P|RABEPK_ENST00000394124.4_3'UTR|RABEPK_ENST00000394125.4_Silent_p.P164P|RABEPK_ENST00000373544.1_3'UTR	NM_005833.3	NP_005824.2	Q7Z6M1	RABEK_HUMAN	Rab9 effector protein with kelch motifs	164		NA			receptor-mediated endocytosis|vesicle docking involved in exocytosis	endosome membrane|plasma membrane				NS(1)|cervix(1)|endometrium(1)|large_intestine(2)|lung(3)|ovary(2)|prostate(1)|skin(1)|upper_aerodigestive_tract(2)|urinary_tract(1)	15						GTGCCCAGCCCGTGCAGGACA	0.557		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						89	77	81	NA		NA	NA	9		NA											NA				127982945		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000136933	HGNC:16896	NM_005833	Approved	uc004bpi.3	NA	O00568|Q69YR2|Q6FHA4|Q6IBG7|Q6P092|Q86Y76|Q9BWB1	ENST00000373538.3	37	CCDS6862.1																																																																																			RABEPK-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000054064.1	-4.644769	KEEP		+	7.304971	0.065574	4	57	---	---	---	---	1	0.9730879	8	79	0	46	5	61	0	46	2	0	0	0	0	0	46	5	61	0	46	2	TP
SPTAN1	6709	broad.mit.edu	37	9	131388756	131388756	+	Silent	SNP	C	C	A			THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	g.chr9:131388756C>A	ENST00000372739.3	+	49	6476	c.6366C>A	c.(6364-6366)ccC>ccA	p.P2122P	SPTAN1_ENST00000372731.4_Silent_p.P2117P|SPTAN1_ENST00000358161.5_Silent_p.P2122P	NM_001130438.2	NP_001123910.1	Q13813	SPTA2_HUMAN	spectrin, alpha, non-erythrocytic 1	2117		NA			actin filament capping|axon guidance|cellular component disassembly involved in apoptosis	cytosol|intracellular membrane-bounded organelle|membrane fraction|microtubule cytoskeleton|spectrin	actin binding|calcium ion binding|calmodulin binding|structural constituent of cytoskeleton	p.P2117P(1)		NS(2)|breast(8)|cervix(2)|endometrium(6)|kidney(4)|large_intestine(21)|liver(1)|lung(25)|ovary(5)|pancreas(1)|prostate(4)|skin(3)|stomach(1)|upper_aerodigestive_tract(2)|urinary_tract(2)	87						TAACAGACCCCGTGCGCTGCA	0.562		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NSCLC(120;833 1744 2558 35612 37579)					NA		NA		NA		1	Substitution - coding silent(1)	lung(1)					NA						104	109	107	NA		NA	NA	9		NA											NA				131388756		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000197694	HGNC:11273	NM_003127	Approved	uc004bvm.4	NA	Q13186|Q15324|Q16606|Q59EF1|Q5VXV5|Q5VXV6|Q7Z6M5|Q9P0V0	ENST00000372739.3	37	CCDS48036.1																																																																																			SPTAN1-005	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000054473.1	-35.052197	KEEP		+	7.747664	0.028571	5	170	---	---	---	---	1	0.998412	27	495	0	132	5	178	0	132	2	0	0	0	0	0	132	5	178	0	132	2	TP
OIT3	170392	broad.mit.edu	37	10	74671559	74671559	+	Missense_Mutation	SNP	G	G	T	rs148833304		THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	g.chr10:74671559G>T	ENST00000334011.5	+	5	970	c.752G>T	c.(751-753)cGg>cTg	p.R251L		NM_152635.1	NP_689848.1	Q8WWZ8	OIT3_HUMAN	oncoprotein induced transcript 3	251		NA				nuclear envelope	calcium ion binding	p.R251Q(1)		autonomic_ganglia(1)|cervix(1)|endometrium(1)|kidney(2)|large_intestine(9)|liver(2)|lung(14)|ovary(2)|prostate(1)|skin(2)	35	Prostate(51;0.0198)					GAATGTCCCCGGGGCCTGGTG	0.517		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Colon(7;19 345 13446 17537)					NA		NA		NA		1	Substitution - Missense(1)	prostate(1)					NA						136	122	127	NA		NA	NA	10		NA											NA				74671559		2203	4300	6503	SO:0001583	missense			ENSG00000138315	HGNC:29953	NM_152635	Approved	uc001jte.1	NA	A0AVP3|Q8N1M8	ENST00000334011.5	37	CCDS7318.1	.	.	.	.	.	.	.	.	.	.	G	23.6	4.434894	0.83885	.	.	ENSG00000138315	ENST00000334011;ENST00000415725	D	0.96396	-4.0	5.96	5.96	0.96718	Epidermal growth factor-like (1);	0.000000	0.51477	D	0.000083	D	0.95701	0.8602	L	0.33137	0.985	0.58432	D	0.999994	D	0.57899	0.981	P	0.52481	0.7	D	0.94628	0.7819	10	0.36615	T	0.2	-15.2	20.422	0.99049	0.0:0.0:1.0:0.0	.	251	Q8WWZ8	OIT3_HUMAN	L	251	ENSP00000333900:R251L	ENSP00000333900:R251L	R	+	2	0	OIT3	74341565	1.000000	0.71417	1.000000	0.80357	0.993000	0.82548	9.018000	0.93657	2.832000	0.97577	0.655000	0.94253	CGG	OIT3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000048596.1	-11.200279	KEEP		+	7.522783	0.055556	5	85	---	---	---	---	1	0.2871537	2	14	1	70	5	89	1	70	2	0	0	0	0	1	70	5	89	1	70	2	TP
TRMT112	51504	broad.mit.edu	37	11	64084377	64084377	+	Missense_Mutation	SNP	C	C	A			THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	g.chr11:64084377C>A	ENST00000544844.1	-	4	891	c.334G>T	c.(334-336)Ggg>Tgg	p.G112W	TRMT112_ENST00000308774.2_Missense_Mutation_p.G107W|TRMT112_ENST00000535750.1_Missense_Mutation_p.G68W|PRDX5_ENST00000265462.4_5'Flank|TRMT112_ENST00000539854.1_3'UTR|TRMT112_ENST00000535126.1_3'UTR|PRDX5_ENST00000352435.4_5'Flank|PRDX5_ENST00000347941.4_5'Flank			Q9UI30	TR112_HUMAN	tRNA methyltransferase 11-2 homolog (S. cerevisiae)	112	TRM112.	NA			peptidyl-glutamine methylation	protein complex	protein binding|protein methyltransferase activity			large_intestine(1)|upper_aerodigestive_tract(1)	2						TTGGGGATCCCGCGGCTGATG	0.542		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						69	75	73	NA		NA	NA	11		NA											NA				64084377		2201	4294	6495	SO:0001583	missense			ENSG00000173113	HGNC:26940	NM_016404	Approved	uc001nzt.3	NA	B2R539|Q3MHC7|Q8N2Z4	ENST00000544844.1	37	CCDS8068.1	.	.	.	.	.	.	.	.	.	.	C	25.6	4.652842	0.88056	.	.	ENSG00000173113	ENST00000535750;ENST00000544844;ENST00000308774	.	.	.	5.0	4.09	0.47781	.	0.061499	0.64402	D	0.000005	T	0.80586	0.4651	M	0.88979	2.995	0.80722	D	1	D	0.89917	1.0	D	0.97110	1.0	D	0.83829	0.0251	9	0.87932	D	0	.	11.4624	0.50219	0.0:0.9121:0.0:0.0879	.	112	Q9UI30	TR112_HUMAN	W	68;112;107	.	ENSP00000309433:G107W	G	-	1	0	TRMT112	63840953	1.000000	0.71417	0.998000	0.56505	0.972000	0.66771	4.821000	0.62679	1.489000	0.48450	0.655000	0.94253	GGG	TRMT112-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000396598.2	-29.358237	KEEP		-	6.592953	0.033113	5	146	---	---	---	---	1	0.9999985	2	1889	0	115	5	157	0	115	2	0	0	0	0	0	115	5	157	0	115	2	TP
NUMA1	0	broad.mit.edu	37	11	71727066	71727066	+	Silent	SNP	G	G	T			THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	g.chr11:71727066G>T	ENST00000393695.3	-	15	1814	c.1483C>A	c.(1483-1485)Cgg>Agg	p.R495R	NUMA1_ENST00000351960.6_Intron|RP11-849H4.4_ENST00000502284.1_RNA|NUMA1_ENST00000358965.6_Silent_p.R495R	NM_006185.2	NP_006176.2	Q14980	NUMA1_HUMAN	nuclear mitotic apparatus protein 1	495		NA			G2/M transition of mitotic cell cycle|mitotic anaphase|nucleus organization	chromosome|cytosol|nucleoplasm|spindle microtubule|spindle pole	protein binding|structural molecule activity			central_nervous_system(1)|endometrium(7)|haematopoietic_and_lymphoid_tissue(3)|kidney(4)|large_intestine(12)|lung(20)|ovary(5)|prostate(2)|skin(3)|stomach(1)|upper_aerodigestive_tract(4)|urinary_tract(3)	65						GCAGTCAACCGGGCCCCATGA	0.612		NA	T	RARA	APL		NA				OREG0021187	type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip)		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA				Dom	yes		11	11q13	4926	nuclear mitotic apparatus protein 1	NA	L	0							NA						66	71	69	NA		NA	NA	11		NA											NA				71727066		2200	4293	6493	SO:0001819	synonymous_variant				HGNC:8059		Approved	uc001orl.1	1132	Q14981	ENST00000393695.3	37	CCDS31633.1																																																																																			NUMA1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000395769.1	-23.774854	KEEP		-	9.602089	0.040816	6	141	---	---	---	---	1	0.9993154	2	406	0	111	6	150	0	111	2	0	0	0	0	0	111	6	150	0	111	2	TP
TAS2R14	50840	broad.mit.edu	37	12	11090893	11090893	+	Missense_Mutation	SNP	C	C	A			THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	g.chr12:11090893C>A	ENST00000537503.1	-	1	969	c.914G>T	c.(913-915)gGg>gTg	p.G305V	PRR4_ENST00000536668.1_Intron|TAS2R14_ENST00000381852.4_5'UTR	NM_023922.1	NP_076411.1	Q9NYV8	T2R14_HUMAN	taste receptor, type 2, member 14	305		NA			detection of chemical stimulus involved in sensory perception of bitter taste		bitter taste receptor activity			central_nervous_system(1)|endometrium(1)|large_intestine(2)|lung(3)|upper_aerodigestive_tract(1)	8						TGAGGGCTCCCCATCTTTGAA	0.368		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						58	59	59	NA		NA	NA	12		NA											NA				11090893		2202	4299	6501	SO:0001583	missense			ENSG00000212127	HGNC:14920	NM_023922	Approved	uc010shi.2	NA	Q645X3	ENST00000537503.1	37	CCDS8637.1	.	.	.	.	.	.	.	.	.	.	C	4.494	0.091692	0.08632	.	.	ENSG00000212127	ENST00000537503	T	0.36340	1.26	3.01	-0.245	0.13027	.	3.623310	0.02187	U	0.061003	T	0.16769	0.0403	N	0.05230	-0.09	0.09310	N	1	B	0.11235	0.004	B	0.14578	0.011	T	0.09773	-1.0659	10	0.23891	T	0.37	.	1.0232	0.01522	0.3022:0.3691:0.1863:0.1424	.	305	Q9NYV8	T2R14_HUMAN	V	305	ENSP00000441949:G305V	ENSP00000375094:G305V	G	-	2	0	TAS2R14	10982160	0.000000	0.05858	0.000000	0.03702	0.025000	0.11179	-0.039000	0.12124	-0.077000	0.12752	0.609000	0.83330	GGG	TAS2R14-001	KNOWN	upstream_ATG|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000370194.4	-8.696587	KEEP		-	6.483342	0.064935	5	72	---	---	---	---	1	0.9186504	3	49	0	70	7	77	0	70	2	0	0	0	0	0	70	7	77	0	70	2	TP
MYL6	4637	broad.mit.edu	37	12	56555209	56555209	+	3'UTR	SNP	C	C	A			THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	g.chr12:56555209C>A	ENST00000550697.1	+	0	752				RP11-603J24.18_ENST00000548571.1_RNA|MYL6_ENST00000549566.1_3'UTR|MYL6_ENST00000547649.1_3'UTR|RP11-977G19.5_ENST00000553176.1_RNA|MYL6_ENST00000293422.5_3'UTR|MYL6_ENST00000548400.1_3'UTR|MYL6_ENST00000348108.4_3'UTR|MYL6_ENST00000549017.1_3'UTR|MYL6_ENST00000547408.1_Intron|MYL6_ENST00000548580.1_3'UTR	NM_021019.4	NP_066299.2	P60660	MYL6_HUMAN	myosin, light chain 6, alkali, smooth muscle and non-muscle	NA		NA			axon guidance|muscle filament sliding|skeletal muscle tissue development	cytosol|unconventional myosin complex	actin-dependent ATPase activity|calcium ion binding|motor activity|structural constituent of muscle			large_intestine(1)|lung(1)|ovary(1)|prostate(3)|skin(1)	7			OV - Ovarian serous cystadenocarcinoma(18;0.0979)			AGGACCTTCCCAGTCTCCCCA	0.547		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						206	167	180	NA		NA	NA	12		NA											NA				56555209		2203	4300	6503	SO:0001624	3_prime_UTR_variant				HGNC:7587		Approved	uc001sjx.2	NA	P16475|P24572|P24573|Q12790|Q561V9|Q6IAZ0|Q6IPY5	ENST00000550697.1	37	CCDS8906.1																																																																																			MYL6-003	KNOWN	NAGNAG_splice_site|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000407928.3	-26.490534	KEEP		+	8.044056	0.039735	6	145	---	---	---	---	1	1	4	6544	0	131	6	178	0	131	2	0	0	0	0	0	131	6	178	0	131	2	TP
ANKLE2	23141	broad.mit.edu	37	12	133311085	133311085	+	Missense_Mutation	SNP	G	G	T			THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	g.chr12:133311085G>T	ENST00000539605.1	-	9	8275	c.1591C>A	c.(1591-1593)Cag>Aag	p.Q531K	ANKLE2_ENST00000542282.1_5'Flank|ANKLE2_ENST00000357997.5_Missense_Mutation_p.Q593K|ANKLE2_ENST00000542657.1_5'Flank|ANKLE2_ENST00000337516.5_Missense_Mutation_p.Q593K|ANKLE2_ENST00000542374.1_5'UTR			Q86XL3	ANKL2_HUMAN	ankyrin repeat and LEM domain containing 2	593		NA				cytoplasm|integral to membrane|nuclear envelope				NS(2)|autonomic_ganglia(1)|breast(2)|cervix(1)|endometrium(5)|haematopoietic_and_lymphoid_tissue(4)|kidney(3)|large_intestine(4)|lung(20)|ovary(1)|urinary_tract(2)	45	all_neural(191;0.0982)|Medulloblastoma(191;0.163)	all_epithelial(31;0.0176)|Lung NSC(355;0.204)		OV - Ovarian serous cystadenocarcinoma(86;2.3e-08)|Epithelial(86;1.56e-07)|all cancers(50;4.94e-06)		AGGCCTTCCTGGGAAGACAGA	0.458		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						175	181	179	NA		NA	NA	12		NA											NA				133311085		1882	4111	5993	SO:0001583	missense			ENSG00000176915	HGNC:29101		Approved	uc001ukx.2	NA	O75176|Q6P6A5|Q8TAZ9|Q96DH4	ENST00000539605.1	37		.	.	.	.	.	.	.	.	.	.	g	18.66	3.672622	0.67928	.	.	ENSG00000176915	ENST00000539605;ENST00000357997;ENST00000337516	T;T;T	0.50277	0.75;0.75;0.75	5.85	5.85	0.93711	.	0.226096	0.46442	D	0.000295	T	0.54532	0.1864	L	0.50919	1.6	0.32283	N	0.56737	D;D	0.59357	0.963;0.985	P;P	0.51079	0.491;0.658	T	0.55560	-0.8122	10	0.22109	T	0.4	-15.8384	20.1653	0.98150	0.0:0.0:1.0:0.0	.	593;593	Q86XL3-2;Q86XL3	.;ANKL2_HUMAN	K	531;593;593	ENSP00000446268:Q531K;ENSP00000350686:Q593K;ENSP00000337651:Q593K	ENSP00000337651:Q593K	Q	-	1	0	ANKLE2	131821158	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	2.271000	0.43364	2.768000	0.95171	0.655000	0.94253	CAG	ANKLE2-002	KNOWN	alternative_5_UTR|basic	protein_coding	NA	protein_coding	OTTHUMT00000397711.1	-54.171374	KEEP		-	6.815298	0.024691	6	237	---	---	---	---	1	0.7770027	12	90	0	197	7	262	0	197	2	0	0	0	0	0	197	7	262	0	197	2	TP
DICER1	23405	broad.mit.edu	37	14	95556886	95556886	+	Missense_Mutation	SNP	T	T	G			THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	g.chr14:95556886T>G	ENST00000526495.1	-	29	6009	c.5718A>C	c.(5716-5718)agA>agC	p.R1906S	DICER1_ENST00000556045.1_Missense_Mutation_p.R804S|DICER1_ENST00000527414.1_Missense_Mutation_p.R1906S|DICER1_ENST00000527416.2_5'UTR|DICER1_ENST00000393063.1_Missense_Mutation_p.R1906S|DICER1_ENST00000343455.3_Missense_Mutation_p.R1906S|DICER1_ENST00000541352.1_3'UTR			Q9UPY3	DICER_HUMAN	dicer 1, ribonuclease type III	1906	DRBM.	NA			negative regulation of Schwann cell proliferation|negative regulation of transcription from RNA polymerase II promoter|nerve development|neuron projection morphogenesis|peripheral nervous system myelin formation|positive regulation of myelination|positive regulation of Schwann cell differentiation|pre-miRNA processing|production of siRNA involved in RNA interference|targeting of mRNA for destruction involved in RNA interference	cytosol|RNA-induced silencing complex	ATP binding|ATP-dependent helicase activity|double-stranded RNA binding|metal ion binding|protein binding|ribonuclease III activity			NS(1)|autonomic_ganglia(1)|biliary_tract(1)|breast(1)|central_nervous_system(1)|endometrium(13)|kidney(3)|large_intestine(10)|lung(33)|ovary(1)|pancreas(1)|prostate(3)|skin(3)|upper_aerodigestive_tract(3)	75		all_cancers(154;0.0621)|all_epithelial(191;0.223)		Epithelial(152;0.211)|COAD - Colon adenocarcinoma(157;0.215)		GGAGGGCTCTTCTTGCTGCTG	0.418		NA	"""Mis F, N"""		"""sex cord-stromal tumour, TGCT, embryonal rhadomyosarcoma"""	pleuropulmonary blastoma	NA		Familial Multinodular Goiter ;DICER 1 syndrome					NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			yes	Rec	yes	Familial Pleuropulmonary Blastoma	14	14q32.13	23405	"""dicer 1, ribonuclease type III """	NA	"""E, M, O"""	0							NA						190	190	190	NA		NA	NA	14		NA											NA				95556886		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Adolescent Multinodular Goiter, incl. Multinodular Euthyroid Goiter & Non-Medullary Thyroid Cancer;incl. Pleuropulmonary Blastoma, Familial ; Cystic Nephroma, Familial	ENSG00000100697	HGNC:17098		Approved	uc001ydw.2	NA	A7E2D3|O95943|Q9UQ02	ENST00000526495.1	37	CCDS9931.1	.	.	.	.	.	.	.	.	.	.	T	19.50	3.839208	0.71373	.	.	ENSG00000100697	ENST00000343455;ENST00000526495;ENST00000393063;ENST00000527414;ENST00000556045	T;T;T;T;T	0.63417	-0.04;-0.04;-0.04;-0.04;-0.04	5.96	3.07	0.35406	Double-stranded RNA-binding (2);Double-stranded RNA-binding-like (1);	0.000000	0.85682	D	0.000000	T	0.66934	0.2840	L	0.44542	1.39	0.80722	D	1	D;D	0.63046	0.992;0.992	D;D	0.68765	0.96;0.96	T	0.62859	-0.6765	10	0.33940	T	0.23	-26.3038	8.9484	0.35773	0.0:0.2687:0.0:0.7313	.	804;1906	B3KRG4;Q9UPY3	.;DICER_HUMAN	S	1906;1906;1906;1906;804	ENSP00000343745:R1906S;ENSP00000437256:R1906S;ENSP00000376783:R1906S;ENSP00000435681:R1906S;ENSP00000451041:R804S	ENSP00000343745:R1906S	R	-	3	2	DICER1	94626639	0.999000	0.42202	0.977000	0.42913	0.986000	0.74619	0.377000	0.20552	0.943000	0.37553	0.533000	0.62120	AGA	DICER1-004	KNOWN	alternative_5_UTR|basic|exp_conf|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000387997.1	196.104666	KEEP		-	199.041243	0.357576	59	106	---	---	---	---	1	1	17	34	0	168	67	114	0	168	2	1	1	251	672	0	168	67	114	0	168	2	TP
JMJD7-PLA2G4B	0	broad.mit.edu	37	15	42135867	42135867	+	Intron	SNP	C	C	A			THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	g.chr15:42135867C>A	ENST00000382448.4	+	16	1445				JMJD7-PLA2G4B_ENST00000458483.1_Intron|JMJD7-PLA2G4B_ENST00000342159.4_Intron|PLA2G4B_ENST00000452633.1_Intron	NM_005090.3	NP_005081.1	P0C869	PA24B_HUMAN		NA		NA			arachidonic acid metabolic process|calcium-mediated signaling|glycerophospholipid catabolic process|inflammatory response|parturition	cytosol|early endosome membrane|extracellular region|mitochondrial membrane	calcium ion binding|calcium-dependent phospholipase A2 activity|calcium-dependent phospholipid binding|lysophospholipase activity			endometrium(3)|kidney(3)|large_intestine(4)|lung(7)|ovary(1)|prostate(3)|skin(1)|soft_tissue(1)|urinary_tract(2)	25						CTTCCTTCCCCGGCCAGACTG	0.632		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						33	31	32	NA		NA	NA	15		NA											NA				42135867		2202	4298	6500	SO:0001627	intron_variant								NA	B4DRT9|O95712|Q19KD5|Q19KD6|Q59GF9|Q8TB10|Q9UKV7	ENST00000382448.4	37	CCDS32202.1																																																																																			JMJD7-PLA2G4B-001	KNOWN	basic|readthrough_transcript|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000103522.2	-5.047946	KEEP		+	7.446442	0.063492	4	59	---	---	---	---	1	0.1783064	10	1	0	41	4	67	0	41	2	0	0	0	0	0	41	4	67	0	41	2	TP
SRRM2	23524	broad.mit.edu	37	16	2817357	2817357	+	Silent	SNP	G	G	T			THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	g.chr16:2817357G>T	ENST00000301740.8	+	11	7377	c.6828G>T	c.(6826-6828)gcG>gcT	p.A2276A	AC092117.2_ENST00000581119.1_RNA	NM_016333.3	NP_057417.3	Q9UQ35	SRRM2_HUMAN	serine/arginine repetitive matrix 2	2276	Ala-rich.|Ser-rich.	NA				Cajal body|catalytic step 2 spliceosome|nuclear speck	C2H2 zinc finger domain binding|protein N-terminus binding|RNA binding			breast(3)|central_nervous_system(1)|cervix(3)|endometrium(10)|haematopoietic_and_lymphoid_tissue(1)|kidney(6)|large_intestine(20)|lung(34)|ovary(6)|pancreas(3)|prostate(2)|skin(6)|upper_aerodigestive_tract(3)|urinary_tract(7)	105						CCAGAACAGCGGTGGCACCTT	0.642		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						89	93	92	NA		NA	NA	16		NA											NA				2817357		2198	4300	6498	SO:0001819	synonymous_variant			ENSG00000167978	HGNC:16639		Approved	uc002crk.3	NA	A6NKB9|D3DU97|O15038|O94803|Q6NSL3|Q6PIM3|Q6PK40|Q8IW17|Q96GY7|Q9P0G1|Q9UHA8|Q9UQ36|Q9UQ37|Q9UQ38|Q9UQ40	ENST00000301740.8	37	CCDS32373.1																																																																																			SRRM2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000436411.1	-43.894076	KEEP		+	7.232002	0.028708	6	203	---	---	---	---	1	0.9996847	2	690	0	159	6	218	0	159	2	0	0	0	0	0	159	6	218	0	159	2	TP
ENKD1	84080	broad.mit.edu	37	16	67698919	67698919	+	Silent	SNP	G	G	T			THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	g.chr16:67698919G>T	ENST00000243878.4	-	3	754	c.433C>A	c.(433-435)Cgg>Agg	p.R145R	ENKD1_ENST00000602409.1_5'UTR|ENKD1_ENST00000602644.1_Silent_p.R145R|C16orf86_ENST00000403458.4_5'Flank	NM_032140.1	NP_115516.1			enkurin domain containing 1	NA		NA						p.R145R(1)			NA						GCCTTGACCCGGGACTCCACC	0.592		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		1	Substitution - coding silent(1)	lung(1)					NA						84	93	90	NA		NA	NA	16		NA											NA				67698919		2198	4300	6498	SO:0001819	synonymous_variant			ENSG00000124074	HGNC:25246	NM_032140	Approved		NA		ENST00000243878.4	37	CCDS10844.1																																																																																			ENKD1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000268884.1	-26.209439	KEEP		-	6.313226	0.029851	4	130	---	---	---	---	1	0.5990827	3	60	0	120	4	139	0	120	2	0	0	0	0	0	120	4	139	0	120	2	TP
TCEB3B	51224	broad.mit.edu	37	18	44561205	44561205	+	Missense_Mutation	SNP	G	G	T			THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	g.chr18:44561205G>T	ENST00000332567.4	-	1	783	c.431C>A	c.(430-432)cCg>cAg	p.P144Q	KATNAL2_ENST00000356157.7_Intron|KATNAL2_ENST00000245121.5_Intron|KATNAL2_ENST00000592005.1_Intron	NM_016427.2	NP_057511.2	Q8IYF1	ELOA2_HUMAN	transcription elongation factor B polypeptide 3B (elongin A2)	144		NA			regulation of transcription elongation, DNA-dependent|transcription from RNA polymerase II promoter	integral to membrane|nucleus	DNA binding			breast(1)|cervix(3)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(15)|lung(24)|ovary(2)|pancreas(2)|prostate(1)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	58						GTGAGACCTCGGGTGAGGTCT	0.647		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						52	60	58	NA		NA	NA	18		NA											NA				44561205		2203	4300	6503	SO:0001583	missense			ENSG00000206181	HGNC:30771	NM_016427	Approved	uc002lcr.1	NA	Q9P2V9	ENST00000332567.4	37	CCDS11932.1	.	.	.	.	.	.	.	.	.	.	G	7.049	0.564107	0.13498	.	.	ENSG00000206181	ENST00000332567	T	0.06068	3.35	2.46	-4.91	0.03085	.	58.353000	0.00166	N	0.000010	T	0.02929	0.0087	N	0.14661	0.345	0.09310	N	1	P	0.34955	0.477	B	0.25506	0.061	T	0.33650	-0.9860	10	0.18710	T	0.47	1.2748	4.6425	0.12556	0.0:0.3554:0.3509:0.2938	.	144	Q8IYF1	ELOA2_HUMAN	Q	144	ENSP00000331302:P144Q	ENSP00000331302:P144Q	P	-	2	0	TCEB3B	42815203	0.000000	0.05858	0.000000	0.03702	0.000000	0.00434	-0.768000	0.04715	-1.275000	0.02417	-1.050000	0.02344	CCG	TCEB3B-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000255900.1	-23.967076	KEEP		-	11.127909	0.044304	7	151	---	---	---	---	1	0.7104001	56	1	0	118	7	161	0	118	2	0	0	0	0	0	118	7	161	0	118	2	TP
WDR7	23335	broad.mit.edu	37	18	54603138	54603138	+	Splice_Site	SNP	T	T	C			THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	g.chr18:54603138T>C	ENST00000254442.3	+	23	4042		c.e23+2		WDR7_ENST00000357574.3_Splice_Site|WDR7_ENST00000589935.1_Intron	NM_015285.2	NP_056100.2	Q9Y4E6	WDR7_HUMAN	WD repeat domain 7	NA		NA								NS(1)|breast(5)|cervix(1)|endometrium(6)|kidney(2)|large_intestine(14)|lung(37)|ovary(3)|prostate(2)|skin(4)|upper_aerodigestive_tract(3)	78				Lung(128;0.0238)|Colorectal(16;0.0296)		GCCAAAGAGGTGAGCGGAACT	0.517		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						81	80	80	NA		NA	NA	18		NA											NA				54603138		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000091157	HGNC:13490		Approved	uc002lgk.1	NA	A7E2C8|Q86UX5|Q86VP2|Q96PS7	ENST00000254442.3	37	CCDS11962.1	.	.	.	.	.	.	.	.	.	.	T	23.2	4.388165	0.82902	.	.	ENSG00000091157	ENST00000254442;ENST00000357574;ENST00000444065;ENST00000398311	.	.	.	5.5	5.5	0.81552	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	15.2571	0.73593	0.0:0.0:0.0:1.0	.	.	.	.	.	-1	.	.	.	+	.	.	WDR7	52754136	1.000000	0.71417	1.000000	0.80357	0.934000	0.57294	7.727000	0.84838	2.100000	0.63781	0.477000	0.44152	.	WDR7-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000256062.1	3.719588	KEEP	Intron	+	19.685268	0.1	10	90	---	---	---	---	1	0.5038754	3	1	1	96	10	101	1	96	3	0	0	0	0	1	96	10	101	1	96	2	TP
GPI	2821	broad.mit.edu	37	19	34884860	34884860	+	Silent	SNP	C	C	A			THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	THCA-TCGA-EM-A2CT-Tumor-SM-29SRZ	THCA-TCGA-EM-A2CT-Normal-SM-29SS4	g.chr19:34884860C>A	ENST00000415930.3	+	12	1154	c.984C>A	c.(982-984)ccC>ccA	p.P328P	GPI_ENST00000356487.5_Silent_p.P317P|GPI_ENST00000586425.1_Silent_p.P317P	NM_001184722.1	NP_001171651.1	P06744	G6PI_HUMAN	glucose-6-phosphate isomerase	317		NA			angiogenesis|gluconeogenesis|glycolysis|hemostasis|humoral immune response	cytosol|extracellular space|nucleus|plasma membrane	cytokine activity|glucose-6-phosphate isomerase activity|growth factor activity			breast(1)|central_nervous_system(1)|endometrium(1)|kidney(1)|large_intestine(5)|lung(11)|ovary(1)|prostate(1)|skin(2)|upper_aerodigestive_tract(1)	25	Esophageal squamous(110;0.162)					AGAACGCCCCCGTCTTGCTGG	0.617		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						117	111	113	NA		NA	NA	19		NA											NA				34884860		2203	4300	6503	SO:0001819	synonymous_variant				HGNC:4458		Approved	uc002nvg.2	NA	Q9BRD3|Q9BSK5|Q9UHE6	ENST00000415930.3	37	CCDS54246.1																																																																																			GPI-001	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000451687.3	-22.765414	KEEP		+	8.368973	0.043165	6	133	---	---	---	---	1	0.9999998	7	1203	0	138	7	148	0	138	2	0	0	0	0	0	138	7	148	0	138	2	TP
